Cargando…
ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study
Introduction: The COVID-19 pandemic posed a major challenge in cancer care worldwide, which might have an impact on the management of hematologic malignancies. Aims: To compare the characteristics, management, and outcomes of diffuse large B-cell lymphoma (DLBCL) patients diagnosed during the first...
Autores principales: | Giladi, Odil, Bagnato, Gianmarco, Gentilini, Marianna, Shimony, Shai, Pasvolsky, Oren, Berger, Tamar, Itchaki, Gilad, Raanani, Pia, Broccoli, Alessandro, Stefoni, Vittorio Stefoni, Lolli, Ginevra, Argnani, Lisa, Zinzani, Pier Luigi, Gurion, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489237/ http://dx.doi.org/10.1016/S2152-2650(22)01524-5 |
Ejemplares similares
-
Poster: ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study
por: Giladi, Odil, et al.
Publicado: (2022) -
ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry
por: Gavrilina, Olga, et al.
Publicado: (2021) -
ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study
por: Goudsmit, Anouk, et al.
Publicado: (2021) -
ABCL-334: Impact of COVID-19 Pandemic on Treatment Duration in Curable Cancers: Comparison of Patients with DLBCL Treated Before and During: A Retrospective Record-Based Study
por: Anandaradje, Annuja, et al.
Publicado: (2021) -
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
por: Stefoni, Vittorio, et al.
Publicado: (2022)